PAK1 INHIBITION FOR TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

14845361

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods are disclosed for treating acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) using inhibition of p21 protein (Cdc42/Rac)-activated kinase (PAK1).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALBERT EINSTEIN COLLEGE OF MEDICINE INC1300 MORRIS PARK AVENUE BRONX NY 10461

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
PANDOLFI, ASHLEY M NEW YORK, US 1 4
STANLEY, ROBERT F NEW YORK, US 2 4
STEIDL, ULRICH G NEW ROCHELLE, US 7 10

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation